INR 51.69
(3.44%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 961.95 Million INR | 10.0% |
2022 | 874.48 Million INR | 12.98% |
2021 | 774.04 Million INR | 3.45% |
2020 | 748.22 Million INR | -0.59% |
2019 | 752.69 Million INR | -1.36% |
2018 | 763.09 Million INR | 28.5% |
2017 | 593.85 Million INR | 22.68% |
2016 | 484.08 Million INR | 6.29% |
2015 | 455.42 Million INR | 27.41% |
2014 | 357.44 Million INR | 14.42% |
2013 | 312.4 Million INR | 70.47% |
2012 | 183.25 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q1 | - INR | -100.0% |
2023 Q2 | 1.02 Billion INR | 0.0% |
2023 FY | 961.95 Million INR | 10.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 961.95 Million INR | 0.0% |
2022 FY | 874.48 Million INR | 12.98% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 961.86 Million INR | 0.0% |
2022 Q4 | 874.48 Million INR | 0.0% |
2021 Q2 | 724.92 Million INR | 0.0% |
2021 FY | 774.04 Million INR | 3.45% |
2021 Q4 | 774.04 Million INR | 0.0% |
2020 FY | 748.22 Million INR | -0.59% |
2020 Q2 | 853.23 Million INR | 0.0% |
2020 Q1 | 853.23 Million INR | 13.36% |
2020 Q4 | 748.22 Million INR | -1.05% |
2020 Q3 | 756.2 Million INR | -11.37% |
2019 Q4 | 752.69 Million INR | 0.0% |
2019 Q1 | 703.82 Million INR | -7.77% |
2019 Q3 | 752.69 Million INR | 6.94% |
2019 Q2 | 703.82 Million INR | 0.0% |
2019 FY | 752.69 Million INR | -1.36% |
2018 Q4 | 763.09 Million INR | 0.0% |
2018 FY | 763.09 Million INR | 28.5% |
2018 Q3 | 763.09 Million INR | 21.45% |
2018 Q2 | 628.33 Million INR | 0.0% |
2018 Q1 | 628.33 Million INR | 5.81% |
2017 FY | 593.85 Million INR | 22.68% |
2017 Q1 | 485.91 Million INR | 0.38% |
2017 Q2 | 485.91 Million INR | 0.0% |
2017 Q3 | 593.85 Million INR | 22.21% |
2017 Q4 | 593.85 Million INR | 0.0% |
2016 FY | 484.08 Million INR | 6.29% |
2016 Q4 | 484.08 Million INR | 0.0% |
2015 FY | 455.42 Million INR | 27.41% |
2014 FY | 357.44 Million INR | 14.42% |
2013 FY | 312.4 Million INR | 70.47% |
2012 FY | 183.25 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Ajanta Pharma Limited | 46.38 Billion INR | 97.926% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 73.78% |
Sigachi Industries Limited | 6.94 Billion INR | 86.142% |
Bal Pharma Limited | 3.2 Billion INR | 69.975% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 91.744% |
Lasa Supergenerics Limited | 1.5 Billion INR | 36.239% |
Venus Remedies Limited | 6.26 Billion INR | 84.654% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 81.323% |
Alpa Laboratories Limited | 1.82 Billion INR | 47.325% |
Nectar Lifesciences Limited | 21.91 Billion INR | 95.61% |
Shilpa Medicare Limited | 30.93 Billion INR | 96.89% |
Aarti Drugs Limited | 24.32 Billion INR | 96.045% |
Lupin Limited | 239.97 Billion INR | 99.599% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.787% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.671% |
Windlas Biotech Limited | 6.26 Billion INR | 84.638% |
Suven Life Sciences Limited | 2.84 Billion INR | 66.236% |
Eris Lifesciences Limited | 70.48 Billion INR | 98.635% |
Valiant Laboratories Limited | 3.42 Billion INR | 71.929% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 97.592% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 95.908% |
Ipca Laboratories Limited | 111.01 Billion INR | 99.133% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 92.075% |
Achyut Healthcare Limited | 309.52 Million INR | -210.787% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.887% |
Bajaj HealthCare Limited | 7.65 Billion INR | 87.428% |
RPG Life Sciences Limited | 5.12 Billion INR | 81.244% |
Mankind Pharma Limited | 119.63 Billion INR | 99.196% |
Laurus Labs Limited | 83.87 Billion INR | 98.853% |
Piramal Pharma Limited | 153.11 Billion INR | 99.372% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 76.228% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 99.361% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 98.508% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 99.33% |
Unichem Laboratories Limited | 31.69 Billion INR | 96.965% |
Sequent Scientific Limited | 15.4 Billion INR | 93.755% |
Novartis India Limited | 9.24 Billion INR | 89.6% |
Wanbury Limited | 3.43 Billion INR | 71.995% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 95.732% |
Wockhardt Limited | 76.49 Billion INR | 98.742% |
Themis Medicare Limited | 5.66 Billion INR | 83.017% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 55.686% |
Jubilant Pharmova Limited | 115.48 Billion INR | 99.167% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 96.625% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.752% |
Divi's Laboratories Limited | 154.7 Billion INR | 99.378% |
NATCO Pharma Limited | 69.06 Billion INR | 98.607% |
Gufic Biosciences Limited | 10.92 Billion INR | 91.195% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 95.714% |
Ind-Swift Limited | 6.54 Billion INR | 85.302% |
Procter & Gamble Health Limited | 7.94 Billion INR | 87.89% |
FDC Limited | 24.68 Billion INR | 96.102% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | 46.011% |
Granules India Limited | 55.2 Billion INR | 98.258% |
Medicamen Biotech Limited | 2.94 Billion INR | 67.339% |
Alkem Laboratories Limited | 155.74 Billion INR | 99.382% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 91.077% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -104.311% |
Brooks Laboratories Limited | 904.45 Million INR | -6.357% |
Megasoft Limited | 3.65 Billion INR | 73.71% |
ZIM Laboratories Limited | 4.46 Billion INR | 78.471% |
Strides Pharma Science Limited | 58.39 Billion INR | 98.353% |
Neuland Laboratories Limited | 18.32 Billion INR | 94.751% |
Morepen Laboratories Limited | 12.93 Billion INR | 92.561% |
Hikal Limited | 24.87 Billion INR | 96.132% |
Indoco Remedies Limited | 21.44 Billion INR | 95.515% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 96.275% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 59.929% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 71.149% |
Hester Biosciences Limited | 6.62 Billion INR | 85.477% |